PREnatal Syphilis point-of-care ScreenING in an urban low-barrier clinic (PRESSING) study: Protocol for a prospective single arm feasibility trial
8 affiliations
- 1Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- 2Department of Social Work, McMaster University, Hamilton, Ontario, Canada.
- 3YWCA Hamilton, Hamilton, Ontario, Canada.
- 4De dwa da dehs nye>s Aboriginal Health Centre, Hamilton, Ontario, Canada.
- 5Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
- 6Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
- 7Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- 8Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Abstract
Introduction: Syphilis has resurged across North America, including syphilis in pregnancy. Congenital syphilis can be prevented by timely treatment of syphilis in pregnancy, but conventional syphilis screening is problematic for people facing barriers to care. Syphilis point-of-care tests (POCT) have improved prenatal syphilis management in low- and middle-income countries. There is minimal literature regarding POCT feasibility and effectiveness for prenatal syphilis screening in high-income countries, where barriers and challenges may differ. Methods: Academic and community partners co-designed a prospective single-arm feasibility trial to evaluate syphilis POCT implementation at a low-barrier prenatal clinic in Hamilton, Canada. The INSTI HIV/syphilis POCT was integrated into routine clinical care for pregnant people with ≥1 risk factor for syphilis (unstable housing in the past year; substance use or accessing addictions services in the past year; > 1 sexual partner in the past year; history of sexually transmitted or blood-borne infection; presentation to care >20 weeks gestation). Sexual partners of newly diagnosed pregnant people are also offered POCT. Individuals offered POCT are invited to enroll in the study. The primary feasibility outcome is the proportion of pregnant participants who accept POCT at first offer. Secondary feasibility outcomes include valid POCT results on clinician’s first attempt and accurate POCT interpretation by clinicians. Secondary clinical outcomes include time to treatment initiation and completion of treatment among syphilis-positive participants. To promote inclusion of groups facing structural barriers to research, individuals declining study participation are enrolled for limited prospective chart review (primary feasibility outcome only). Target enrollment is N = 62 pregnant participants over 18 months. Baseline participant characteristics and outcomes will be descriptively analyzed. Community-based knowledge mobilization is ongoing. Conclusion: This pilot study will generate novel feasibility data regarding prenatal syphilis screening with POCT in high-income countries and inform design of a multicenter implementation trial. Trial registration: Clinicaltrials.gov NCT06829602; February 17, 2025. https://clinicaltrials.gov/study/NCT06829602
Related
- Impact of Structured Prenatal Counseling on Decision-making and Psychological Outcomes in Indian Women with High-risk Aneuploidy Screening Results: A Prospective Cohort Study
- Prospective field deployment of Swaasa® AI for community-based screening of tuberculosis and other respiratory diseases in Andhra Pradesh: a feasibility and implementation study
- Prevalence of screening markers for HIV, hepatitis B virus, hepatitis C virus, and syphilis and associated factors among voluntary non-remunerated blood donors in Addis Ababa, Ethiopia: a cross-sectional study
- A Modeling Analysis of Strategies for Allocating Emergency Department HIV and Syphilis Screening Funds in California
- Prevalence and clinical significance of α-globin gene subtypes in prenatal thalassemia screening: a focus on the -α3.7III variant in Sanya, Hainan, China
BibTeX
@article{sanya2026prenatal,
title = {{PREnatal Syphilis point-of-care ScreenING in an urban low-barrier clinic (PRESSING) study: Protocol for a prospective single arm feasibility trial}},
author = {Njideka Sanya and Mary-Elizabeth Vaccaro and Medora Uppal and Sarah Glen and Chelsea Kirkby and Tehreem Zafar and Janet Gasparelli and Kate MacNeil and Stephanie Milliken and Jeffrey Pernica and Jacqueline Wong and Donald Brody Duncan and Marek Smieja and Amanda Ramdyal and Robin Lennox and Tim O'Shea and Anna Cvetkovic and Lawrence Mbuagbaw and Suzanne Turner and Laura Erdman},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0360150},
url = {https://doi.org/10.1371/journal.pone.0360150},
note = {CC BY},
}
RIS
TY - JOUR
TI - PREnatal Syphilis point-of-care ScreenING in an urban low-barrier clinic (PRESSING) study: Protocol for a prospective single arm feasibility trial
AU - Njideka Sanya
AU - Mary-Elizabeth Vaccaro
AU - Medora Uppal
AU - Sarah Glen
AU - Chelsea Kirkby
AU - Tehreem Zafar
AU - Janet Gasparelli
AU - Kate MacNeil
AU - Stephanie Milliken
AU - Jeffrey Pernica
AU - Jacqueline Wong
AU - Donald Brody Duncan
AU - Marek Smieja
AU - Amanda Ramdyal
AU - Robin Lennox
AU - Tim O'Shea
AU - Anna Cvetkovic
AU - Lawrence Mbuagbaw
AU - Suzanne Turner
AU - Laura Erdman
PY - 2026
DA - 2026/10/22
JO - PLOS One
DO - 10.1371/journal.pone.0360150
UR - https://doi.org/10.1371/journal.pone.0360150
AB - Introduction: Syphilis has resurged across North America, including syphilis in pregnancy. Congenital syphilis can be prevented by timely treatment of syphilis in pregnancy, but conventional syphilis screening is problematic for people facing barriers to care. Syphilis point-of-care tests (POCT) have improved prenatal syphilis management in low- and middle-income countries. There is minimal literature regarding POCT feasibility and effectiveness for prenatal syphilis screening in high-income countries, where barriers and challenges may differ. Methods: Academic and community partners co-designed a prospective single-arm feasibility trial to evaluate syphilis POCT implementation at a low-barrier prenatal clinic in Hamilton, Canada. The INSTI HIV/syphilis POCT was integrated into routine clinical care for pregnant people with ≥1 risk factor for syphilis (unstable housing in the past year; substance use or accessing addictions services in the past year; > 1 sexual partner in the past year; history of sexually transmitted or blood-borne infection; presentation to care >20 weeks gestation). Sexual partners of newly diagnosed pregnant people are also offered POCT. Individuals offered POCT are invited to enroll in the study. The primary feasibility outcome is the proportion of pregnant participants who accept POCT at first offer. Secondary feasibility outcomes include valid POCT results on clinician’s first attempt and accurate POCT interpretation by clinicians. Secondary clinical outcomes include time to treatment initiation and completion of treatment among syphilis-positive participants. To promote inclusion of groups facing structural barriers to research, individuals declining study participation are enrolled for limited prospective chart review (primary feasibility outcome only). Target enrollment is N = 62 pregnant participants over 18 months. Baseline participant characteristics and outcomes will be descriptively analyzed. Community-based knowledge mobilization is ongoing. Conclusion: This pilot study will generate novel feasibility data regarding prenatal syphilis screening with POCT in high-income countries and inform design of a multicenter implementation trial. Trial registration: Clinicaltrials.gov NCT06829602; February 17, 2025. https://clinicaltrials.gov/study/NCT06829602
SN - 1932-6203
ER -